Skip to content

Investigator

Peter S Klein

UNIVERSITY OF PENNSYLVANIA · funded by NIDDK

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$4.1M

Summed across those awards.

First award
Sep 1, 2024

Latest Mar 15, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Targeting mitophagy through PINK1 splicing in MDS

    $756k

    Mar 15, 2026NIDDKUNIVERSITY OF PENNSYLVANIANIH RePORTER · 11297039 (opens the source filing in a new tab)

  2. R01

    Mitochondrial dysfunction driven by splicing factor mutations in MDS

    $3.2M

    Sep 15, 2025NIDDKUNIVERSITY OF PENNSYLVANIANIH RePORTER · 11234654 (opens the source filing in a new tab)

  3. U2C

    Professional Development

    $147k

    Sep 1, 2024NIDDKUNIVERSITY OF PENNSYLVANIANIH RePORTER · 11168984 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources